Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.21 | 11.21 |
| PEG Ratio (TTM) | -0.01 | 1.27 |
| P/S Ratio (TTM) | 0.66 | 4.80 |
| P/B Ratio (TTM) | 0.64 | 3.36 |
| P/FCF Ratio (TTM) | 4.01 | 22.01 |
| Price to 5YR AVG Earnings Ratio | -0.28 | 31.02 |
| Price to 5YR AVG FCF Ratio | 2.66 | 18.96 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -24.82% | 3.34% |
| ROE (TTM) | -51.19% | 10.11% |
| Net Profit Margin (TTM) | -54.46% | -17.51% |
| ROIC 5YR AVG | -22.96% | 8.16% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 53.46% | -147.84% | 1,440.23% |
| Revenue | -4.82% | -25.21% | -7.51% |
| Net Income | 52.66% | -168.67% | 1,549.79% |
| Cash Flow | 12.69% | -13.09% | 249.39% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.01 | 2.58 |
| Quick Ratio (TTM) | 1.57 | 1.94 |
| D/E Ratio (TTM) | 0.30 | -0.48 |
| Interest Coverage (TTM) | -5.61 | 16.68 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | N/A | 5.03 |
| LTL to 5YR AVG FCF | 1.28 | 4.46 |
| Shares Outstanding Growth 5YR AVG | 36.76% | 28.16% |